Journals / MN Kardiyoloji / 2001 / Cilt: 8 - Sayı: 1

Plasma lipoprotein levels in patients with valvular heart disease

Kalp kapak hastalığı bulunan olgularda lipoprotein düzeyleri

Pages
35–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Lipid profile in patients with heart valve disease represents similiar and different characteristics from that the population who lived in the same region.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Screening of the Turkish population in regard to coronary risk factors revealed that plasma total cholesterol (TK), LDL-cholesterol, and HDL-cholesterol levels were lower when compared to most of the Western contries.
📊
Key Findings & Data:MATERIAL AND METHODS: For these purpose, we enrolled 850 patients (414 male, 436 female, mean age 54,1 ± 17,3) (700 cases retrospectives, 150 cases prospevtives) who admitted to our hospital between January 1995- May 2000.
💡
Conclusion & Impact:CONCLUSION: Lipid profile in patients with heart valve disease represents similiar and different characteristics from that the population who lived in the same region.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Risk faktörleri · Kalp kapağı hastalıkları · Trigliseridler

Abstract

AIM: Screening of the Turkish population in regard to coronary risk factors revealed that plasma total cholesterol (TK), LDL-cholesterol, and HDL-cholesterol levels were lower when compared to most of the Western contries. Triglycerides, on the contrary, were somewhat higher in the male and remarkably higher in the female population. The aim of our study was to determine whole lipid analysis in patients with heart valve disease and comparison of these with that of population who lived in the same region. MATERIAL AND METHODS: For these purpose, we enrolled 850 patients (414 male, 436 female, mean age 54,1 ± 17,3) (700 cases retrospectives, 150 cases prospevtives) who admitted to our hospital between January 1995- May 2000. All patients were older than 20 years of age. Plasma lipid levels were compared to that of the population who lived in Marmara region. RESULTS: When all age groups were considered; TC, HDL-C, LDL-C, and TG levels in our cases were 194±50mg/dl, 43±13mg/dl, 123±42mg/dl and 137±71mg/dl respectively. Total cholesterol levels and TG levels were similiar in our male and female cases. But HDL-cholesterol levels were significantly higher in our female cases (41±11 mg/dl vs 45±14 mg/dl) (p<0.05), and LDL-C levels were significantly higher in our male cases (128±43 mg/dl vs119±40 mg/dl). When all age groups were considered; TC levels were =240 mg/dl in 18% of all patients, LDL-C were =160 mg/dl in 21.5% of all patients, HDL-C levels were = 35 mg/dl in 29.1% of all patients and TG levels were =200 mg/dl in 14.1% of all patients. CONCLUSION: Lipid profile in patients with heart valve disease represents similiar and different characteristics from that the population who lived in the same region.

Özet

AMAÇ: Türkiye de gerçekleştirilen koroner risk faktörleri tarama çalışmalarından elde edilen verilerde, total kolesterol (TK), düşük dansiteli lipoprotein kolesterol (LDL-K) ve yüksek dansiteli lipoprotein kolesterol (HDL-K) değerlerinin diğer birçok ülkede saptanmış değerlere oranla daha düşük, trigliseridlerin (TG) ise erkekte hafif, kadında ise daha belirgin düzeyde yüksek olduğu saptanmıştır. Çalışmamızın amacı koroner arter hastalığı dışında bir nedenle (kalp kapak hastalığı) başvurmuş erişkinlerde ölçülen lipid değerlerini saptamak ve bunun daha önce aynı bölgede yapılmış çalışmalarda saptanan lipid profilini yansıtıp yansıtmadığını incelemektir. GEREÇ VE YÖNTEM: Ocak 1995-Mayıs 2000 tarihleri arasında kalp kapak hastalığı nedeniyle başvuranlardan 20 yaş ve üzerinde olan 850 olgu (414 erkek, 436 kadın, yaş ort. 54.1±17.3) çalışmaya alındı. Bu olgulara ait lipid profili 700 olguda retrospektif ve 150 olguda prospektif olarak saptandı. Lipid profiline ait veriler daha önce Marmara bölgesinde yapılmış çalışmalarda saptanan verilerle karşılaştırıldı. BULGULAR: Ortalama TK=194±50mg/dl, HDL-K=43±13mg/dl, LDL-K=123±42mg/dl, TG=137±71mg/dl olarak saptandı. Bu değerler erkek ve kadında karşılaştırıldığında TK ve TG ortalama değerleri iki cins arasında anlamlı derecede farklı bulunmazken, HDL-K kadında ( 41±11 mg/dl vs 45±14 mg/dl) (p<0.05), LDL-K ise erkek (128±43 mg/dl vs119±40 mg/dl) (p<0.5) cinste anlamlı olarak yüksek bulundu. Total kolesterol tüm olguların %18'inde 240 mg/dl'nin üzerinde bulundu. LDL-K olguların % 2 1.5'inde 160 mg/dl'nin üzerinde saptandı. HDL-K olguların %29.1'inde 35mg/dl'nin altında bulundu. TG olguların %14.1'inde 200 mg/dl'nin üzerinde bulundu. SONUÇ: Bu değerler Türkiye'de yapılmış diğer lipid profili çalışma verileriyle benzer ve farklı özelli kler içermektedir.

🔖

Cite This Article

SÖNMEZ, K., GENÇBAY, M., AKÇAY, A., YILMAZ, A., ONAT, Ö., PALA, S., DURAN, E. N., YEŞİLALTAY, S., DEĞERTEKİN, M., TURAN, F. (2001). Plasma lipoprotein levels in patients with valvular heart disease. MN Kardiyoloji, Cilt: 8 - Sayı: 1, 35–40. https://ajindex.com/articles/297729

References (5)

  1. Onat A, Şurdum-Avcı G, Şenocak M, et al. Türkiye'de erişkinlerde kalp hastalığı ve risk faktörleri sıklığı taraması: 4. kanda kolesterol ve trigliserid düzeyleri. Türk Kardiyol Dern Arş 1991; 19:88. Onat A, Şurdum-Avcı G, Şenocak M, örnek E, Gözükara Y. Plasma lipids and their interrelationship in Turkish adults. J Epidemiol Community Health 1992;46:470. Mahley RW, Bersot TP. Low levels of high-density lipoproteins in the Turkish population: A risk factor for coronary heart disease. Türk Kardiyol Dern Arş 1999;27:37. Bersot TP, Vega GL, Grundy SM, et al. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotrigliseridemic, nonobese Turkish population. J Lipid Res. 1999;40:432. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67:730. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein ch.olesterol levels. The Framingham Study. J Am Med Assoc 1986:256:2835. Castelli WP. The folly of questioning the benefits of cholesterol reduction. Am. Fam Physician 1994;49:567. Onat A, Büyükbeşe MA, Ural E, et al. Marmara bölgesi halkında HDL-kolesterol ile fibrinojen düzeyleri ve bazı etkenlerle ilişkileri. Türk Kardiyol Dern Arş 1997;25:520. Onat A, Ural D, Keleş İ, et al. Marmara bölgesi halkında kanda kolesterol iyi seyrederken, kan basıncı yükselme eğiliminde. Türk Kardiyol Dern Arş 1998;26:18. American Heart Association. Heart and Stroke Facts. 1995;
  2. Statistical Supplement. Dallas, American Heart Association, 1994.
  3. Stamler J, Wentworth D, Neaton JD, for the MRFIT research Group.Is relationship between serum cholesteroland risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc 1986;256:2823. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1329. Keys A. Seven Countries. A Multivariate Analysis of Death and Coronary heart Disease. Harvard University Press,
  4. Cambridge, MA, 1980.
  5. Anderson KM, Castelli WP, Levy D, Cholesterol and mortality. 30 years follow-up from the Framingham Study. J Am Med Assoc 1987;257:2176. Onat A, Surdum Avcı G, Şenocak M et al. Türkiye'de erişkinlerde Kalp hastalığı ve risk faktörleri sıklığı